218 related articles for article (PubMed ID: 30878138)
1. Failure of rechallenge clozapine after agranulocytosis: A case report.
Roméo B; Petillion A; Martelli C; Benyamina A
Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
[No Abstract] [Full Text] [Related]
2. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
Tourian L; Margolese HC
J Clin Psychopharmacol; 2011 Oct; 31(5):665-7. PubMed ID: 21881454
[No Abstract] [Full Text] [Related]
3. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
Vila-Rodriguez F; Tsang P; Barr AM
Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
[No Abstract] [Full Text] [Related]
4. Unsuccessful reexposure to clozapine.
Szarek BL; Goethe JW; Pentz PG
J Clin Psychopharmacol; 1997 Feb; 17(1):71-3. PubMed ID: 9004074
[No Abstract] [Full Text] [Related]
5. Restarting clozapine: a case report.
Barrons E; Johnson E; Nynkowski P
Psychiatr Serv; 1996 Jan; 47(1):92. PubMed ID: 8925356
[No Abstract] [Full Text] [Related]
6. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
Joffe G; Eskelinen S; Sailas E
Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
[No Abstract] [Full Text] [Related]
7. Clozapine-induced eosinopenia correlates with high drug serum levels: A case report.
Compagni C; Salvi V; Corulli M; Rosso R; Gramaglia C
Asian J Psychiatr; 2019 Jun; 43():83-84. PubMed ID: 31100604
[No Abstract] [Full Text] [Related]
8. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.
Ziegenbein M; Calliess IT
J Neuropsychiatry Clin Neurosci; 2006; 18(2):246-7. PubMed ID: 16720806
[No Abstract] [Full Text] [Related]
9. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.
De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD
J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818
[No Abstract] [Full Text] [Related]
12. Combined clozapine and valproic acid treatment-induced agranulocytosis.
Madeb R; Hirschmann S; Kurs R; Turkie A; Modai I
Eur Psychiatry; 2002 Jul; 17(4):238-9. PubMed ID: 12231274
[No Abstract] [Full Text] [Related]
13. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
Comacchio C; Dusi N; Lasalvia A
J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
[No Abstract] [Full Text] [Related]
14. Monitoring in clozapine rechallenge after myocarditis.
Hassan I; Brennan A; Carroll A; Dolan M
Australas Psychiatry; 2011 Aug; 19(4):370-1. PubMed ID: 21879872
[No Abstract] [Full Text] [Related]
15. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
16. Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
Pigato G; Toffanin T; Perini GI
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):153-5. PubMed ID: 18801403
[No Abstract] [Full Text] [Related]
17. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
Ziegenbein M; Sieberer M; Calliess IT; Kropp S
Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043
[No Abstract] [Full Text] [Related]
18. Chronic leukocytosis associated with clozapine treatment.
Sopko MA; Caley CF
Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):141-4. PubMed ID: 20643637
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine: safe during clozapine-induced agranulocytosis.
Oyewumi LK; Al-Semaan Y
J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
[No Abstract] [Full Text] [Related]
20. Morning pseudoneutropenia during clozapine treatment.
Esposito D; Aouillé J; Rouillon F; Limosin F
World J Biol Psychiatry; 2003 Oct; 4(4):192-4. PubMed ID: 14608591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
